Top Qs
Timeline
Chat
Perspective
Levilimab
Anti-IL-6 monoclonal antibody From Wikipedia, the free encyclopedia
Remove ads
Levilimab is an anti-IL-6 monoclonal antibody initially developed to treat rheumatoid arthritis. In 2020, it was approved as a treatment for COVID-19 in Russia.[1][2][3]
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads